Business
Quantum-Si to Participate in the Canaccord Genuity 43rd Annual Growth Conference
BRANFORD, Conn.--(BUSINESS WIRE)-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today
About this update from Quantum-si Incorporated
[{"type":"text","content":" BRANFORD, Conn.--(BUSINESS WIRE)--\nQuantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in the Canaccord Genuity 43rd Annual Growth Conference taking place at the InterContinental Boston Hotel on August 7-10, 2023.\n\n\nJeff Hawkins, Quantum-Si's Chief Executive Officer, will participate in the panel discussion “The Next Generation of Proteomics from the Research and Clinical Perspectives” on Thursday, August 10, at 10:00 AM ET.\n\n\nAdditionally, Jeff Hawkins will participate in a fireside chat on Thursday, August 10, at 12:30 PM ET.\n\n\nA live and archived webcast of the event will be available in the “Investors” section of the Quantum-Si website under Events & Presentations.\n\n\nAbout Quantum-Si Incorporated\nQuantum-Si, The Protein Sequencing CompanyTM, is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at www.quantum-si.com.\n\nView source version on businesswire.com: https://www.businesswire.com/news/home/20230726447394/en/\n\nInvestor\nJuan Avendano\[email protected]\n\n\nMedia\nMichael Sullivan\[email protected]\n\n\nSource: Quantum-Si Incorporated","length":3748,"tagName":"div"}]